Marc Yates

Marc Yates

Marc Yates's picture
Marc Yates is Director of Emerging Markets at Research Partnership and has 30 years’ experience of market research, specializing in healthcare research since 1996. He spent 15 years in Asia, originally based in Shanghai, then Hong Kong before moving to Singapore. In 2011 he relocated to London to take on a broader Emerging Markets role. Marc is a regular speaker at industry events and has presented papers on Emerging Markets at EphMRA and PBIRG conferences. Contact Marc at marcy@researchpartnership.com Research Partnership is one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical industry, we use our expertise and experience to deliver intelligent, tailor-made solutions. We provide strategic recommendations that go beyond research, helping our clients to answer their fundamental business challenges. Find out more at researchpartnership.com

Latest posts from Marc:

Column

Nutraceuticals in India: A...

Dec 21, 2016

As growth begins to plateau in more established territories, attention is...

Column

Nutraceuticals: Rich in Potential

Oct 28, 2016

A shift to preventative health will see nutraceuticals emerge as a growth area...

Column

Understanding the Chronic Disease...

Sep 16, 2016

How can pharma companies make a positive intervention to improve sub-optimal...

Column

Beyond Andrology: Trends in...

Jun 30, 2016

Men’s health in emerging markets is more likely to be brought about by...

Column

The Opportunity for Women’s...

Apr 8, 2016

Challenging awareness, attitudes and access barriers.

Column

Taiwan: Exploring the Healthcare...

Feb 12, 2016

How large is the opportunity for pharma and healthcare companies in Taiwan?

Column

What to Consider When Conducting...

Dec 22, 2015

The need to understand the patient as a key stakeholder is now recognized by...

Column

12 Challenges Big Pharma Faces in...

Nov 16, 2015

What challenges must pharma companies overcome in order to successfully...

Column

Understanding Patient Willingness...

Oct 12, 2015

What steps should pharma and medical device companies take to ensure they get...

Column

Competition from within

Jul 29, 2015

To what extent can Big Pharma expect to face an increasing challenge from...

Pages